XML 31 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]        
Revenues $ 95 $ 195 $ 190 $ 390
Cost of revenues (3) (6) (6) (12)
Gross profit 92 189 184 378
Research and development expenses (6,107) (4,146) (11,604) (7,894)
Less participation by the Office of the Chief Scientist and other parties 1,000 493 3,374 1,543
Research and development expenses, net (5,107) (3,653) (8,230) (6,351)
General and administrative expenses (1,975) (1,420) (3,804) (3,101)
Operating loss (6,990) (4,884) (11,850) (9,074)
Financial income, net 285 394 390 589
Net loss for the period $ (6,705) $ (4,490) $ (11,460) $ (8,485)
Loss per share:        
Basic and diluted net loss per share $ (0.11) $ (0.08) $ (0.19) $ (0.16)
Weighted average number of shares used in computing basic and diluted net loss per share 61,510,550 57,512,930 60,379,352 52,659,430